“…Similar results were found by Gayatri et al where babies delivered at <37 weeks of gestation, 58% in scarred and 47% in unscarred group. 3 There were no still births in our study as compared to 13.2% in the study by Ahmed et al 2 Incidence of still births was 9% and 24% in scarred and unscarred group in the study by Gayatri et al 3 There was no maternal death in this study as in the study by Ahmed et al 2 …”
Section: Discussionsupporting
confidence: 38%
“…3 A slightly higher incidence was found in the study by Ahmed et al (1.3%). 2 The incidence of placenta previa was higher in the women with previous cesaerean section as compared to those with no previous uterine scar i.e. 1.33% and 0.47% respectively.…”
Section: Discussionmentioning
confidence: 94%
“…3 Ahmed et al reported a very high incidence of 26.4% of adherent placenta in their study, hence concluding that probability of placenta 2732 cesaerean is greater in patients with prior 2732 cesaerean section. 2 Anterior previa is commoner in patients with previous 2732 cesaerean section. In our study, significantly higher number of 66.7% cases have anterior previa in scarred uterus and only 32% cases in unscarred uterus (p value = 0.03 S).…”
Section: Discussionmentioning
confidence: 99%
“…1 Almost 30 % maternal deaths in the Asian population are due to major obstetrical haemorrhage in placenta previa, especially due to rise in the incidence of cesearean sections. 2 Significant maternal morbidity in the form of increased incidence of fetalmalpresentation, cesearean delivery, increased blood loss and peripartum hysterectomy have been noted in cases of placenta previa and can lead to prolonged hospitalization in these women. Premature deliveries can occur which lead to higher admission to neonatal intensive care unit and stillbirths.…”
“…Similar results were found by Gayatri et al where babies delivered at <37 weeks of gestation, 58% in scarred and 47% in unscarred group. 3 There were no still births in our study as compared to 13.2% in the study by Ahmed et al 2 Incidence of still births was 9% and 24% in scarred and unscarred group in the study by Gayatri et al 3 There was no maternal death in this study as in the study by Ahmed et al 2 …”
Section: Discussionsupporting
confidence: 38%
“…3 A slightly higher incidence was found in the study by Ahmed et al (1.3%). 2 The incidence of placenta previa was higher in the women with previous cesaerean section as compared to those with no previous uterine scar i.e. 1.33% and 0.47% respectively.…”
Section: Discussionmentioning
confidence: 94%
“…3 Ahmed et al reported a very high incidence of 26.4% of adherent placenta in their study, hence concluding that probability of placenta 2732 cesaerean is greater in patients with prior 2732 cesaerean section. 2 Anterior previa is commoner in patients with previous 2732 cesaerean section. In our study, significantly higher number of 66.7% cases have anterior previa in scarred uterus and only 32% cases in unscarred uterus (p value = 0.03 S).…”
Section: Discussionmentioning
confidence: 99%
“…1 Almost 30 % maternal deaths in the Asian population are due to major obstetrical haemorrhage in placenta previa, especially due to rise in the incidence of cesearean sections. 2 Significant maternal morbidity in the form of increased incidence of fetalmalpresentation, cesearean delivery, increased blood loss and peripartum hysterectomy have been noted in cases of placenta previa and can lead to prolonged hospitalization in these women. Premature deliveries can occur which lead to higher admission to neonatal intensive care unit and stillbirths.…”
“…Among the enrolled patients, 91.5% babies were delivered at gestational age <37 weeks. The mean period of gestation at delivery was 35weeks±3 weeks in present study and the mean birth weight of babies born was 2.18±0.63 kg whereas in a study by Mohamed Alkhatim Alsammani et al 12 the mean period of gestation at delivery was 37weeks±1 weeks whereas the mean birth weight of babies born was 3.0±0.28 kg.…”
Background: The aim of this study was to determine clinical profile, evaluate our antenatal and intraoperative management and see the maternal and perinatal outcome in patients with placenta previa.Methods: A prospective study was carried out in 130 women with placenta previa in the Department of Gynecology, PGIMER, Chandigarh, India between Jan 2015–April 2016. The profile of these patients was recorded in a predesigned proforma and maternal and perinatal outcome analyzed in detail.Results: One third (46/130) of the patients with placenta previa had a history of previous caesarian section, 27% had previous uterine curettage and 82% were multiparous.18% were asymptomatic placenta previa whereas 82% had one or more bleeding episodes. Expectant management was given to 67% patients after first bleeding episode. Majority (92/130) of patients required emergency cesarean section. Due to invasive placentation, 25 patients required cesarean hysterectomy. Ninety percent patients required delivery at ≤37 weeks and neonatal outcome improved with increasing gestation as expected.Conclusions: Reduction in cesarean rate is the major key factor for decreasing the incidence of placenta previa as, as well as placenta accreta and other associated complications as there were no patients diagnosed to have placenta accreta when placenta previa was present without any previous cesarean scar. In cases of invasive placenta, performing a classical CS, not trying to remove the placenta and proceeding directly to hysterectomy resulted in reduced blood loss. Neonatal outcome as well as maternal outcome is best when cesarean is done between 36-37 weeks.
Placenta previa is an independent risk factor for maternal hemorrhagic morbidity. Some risk factors are modifiable, but many are intrinsic to the clinical scenario.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.